Show results for
Refine by
Applications
- Motor-Assisted Therapeutic Exercise Equipment for Parkinson’s Patients
- Physical Therapy Stationary Bicycle for Autism
- Solution for Ultrafast Laser Spectroscopy / Imaging
- Solution for High-Speed 4D Imaging
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Stroke
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Parkinson`s Disease
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Multiple Sclerosis
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Cerebral Palsy
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Traumatic Brain Injuries
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Spinal Cord Injuries
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Cardiac Rehabilitation & Health
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Senior Wellness
- Motor-Assisted Reciprocating Arms / Legs Action Therapy Cycle for Obesity & Weight Loss
Parkinsons Disease Equipment & Supplies In Monaco
78 equipment items found
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1601 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The antibody PD1602 is targeting alpha-synuclein for treatment of Parkinson’s disease. The aim is to develop a disease modifying treatment that stops or slows down disease progression. The project is conducted in collaboration with ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
The drug candidate ABBV-0805 is a monoclonal antibody that selectively binds and eliminates oligomers and protofibrils of alpha-synuclein. The goal is to develop a disease modifying treatment that stops or slows down disease ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
We are developing mGlu4 PAM as a novel orally available treatment for Parkinson's disease. We are currently optimizing multiple chemical series of highly selective mGlu4 PAMs with compounds in early lead ...
Manufactured by:XPhyto Therapeutics Corporation based inVancouver, BRITISH COLUMBIA (CANADA)
Clinical studies are planned in 2021 to demonstrate the efficient transdermal delivery of a well-established Parkinson's disease ...
Manufactured by:AnaSpec based inFremont, CALIFORNIA (USA)
Parkinson's disease is predominantly a movement disorder resulting from degeneration of dopaminergic neurons in the substantia nigra. The cause of the disease is unknown, but substantial evidence suggests that the aggregation of α-synuclein is a critical step in the etiology of Parkinson's disease (PD). ...
by:Pureims B.V. based inRoden, NETHERLANDS
Levodopa Cyclops™ is a levodopa dry powder inhaler for the fast and reliable relief of OFF episodes in Parkinson’s disease. As such, Levodopa Cyclops™ answers a major unmet medical need. Levodopa is the cornerstone in the treatment of Parkinson’s disease for well over 50 years. It is the most effective, ...
Manufactured by:Neuro Device Innovations (NDI) based inCleveland, OHIO (USA)
After more than a decade of research, Professor Grill's lab discovered a way to 'speak' to the area of the brain that controls movement in people with Parkinson's disease. The stimulation patterns were designed to be more effective and/or more energy efficient than standard ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
mGlu2 NAM for the treatment of mild neurocognitive disorders, or mNCD. We are developing mGlu2 NAM as a novel orally available treatment for mNCD associated with Alzheimer’s disease, Parkinson’s disease and depressive disorders. The program is in clinical candidate selection phase and we expect to enter IND enabling studies early in ...
Manufactured by:Kaneka Eurogentec S.A. based inSeraing, BELGIUM
α-Synuclein is a major component of Lewy bodies in the affected neurons in Parkinson's disease. This protein has a mass of 14.5 kDa (140 amino acids long) and consists of a conserved degenerative amino-terminal domain and an acidic carboxyl-terminal with higher sequence divergence. α-Synuclein is predominantly expressed in brain, specifically in ...
Manufactured by:Gerresheimer AG based inDüsseldorf, GERMANY
This belt-worn on-body drug delivery device for small-molecule drugs has been developed for our pharma partner EVER Pharma. The wearable device is used by Parkinson's disease patients for the administration of apomorphine to treat this long-term degenerative disorder of the central nervous system. This device is customizable to be used with suitable other drugs ...
Manufactured by:Shanghai Siyi Intelligent Technology Co., Ltd based inShanghai, CHINA
It allows the wearer to say goodbye to cumbersomeness and uncomfortableness. In the future, it will be a life assistant for patients with stroke, spinal paralysis, arthritis, Parkinson's disease, and the ...
Manufactured by:LTS Lohmann Therapie-Systeme AG based inAndernach, GERMANY
The TTS innovations accommodate individual market positioning and lifecycle management of established products. They are well-suited for patients with special needs, including those with Parkinson’s disease, and are particularly beneficial for children, older adults, and patients with complex care requirements due to easier application and reduced dosage ...
Manufactured by:ReGen Therapeutics Limited based inLondon, UNITED KINGDOM
The complex and the peptides within it are viewed as having potential utility in neurodegenerative illnesses such as Alzheimer’s disease, Parkinson’s Disease, Multiple Sclerosis and Amyotrophic Lateral ...
Manufactured by:ACROBiosystems based inNewark, DELAWARE (USA)
Protein aggregation is a major pathological feature of neurodegenerative diseases such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD). Under pathological conditions, Tau, Amyloid beta, alpha-synuclein, TDP-43, Huntingtin and other proteins ...
Manufactured by:Manus Neurodynamica based inEdinburgh, UNITED KINGDOM
Motion features are translated into biomarkers to provide objective information about movement abnormalities which support diagnosis and monitoring of Parkinson's disease and other impairments. Full audit trail of results. Full monitoring of changes over time. Patented and CE marked as a medical device. Manufacturing setup with QMS according to all relevant ...
Manufactured by:Addex Therapeutics based inGeneva, SWITZERLAND
Dipraglurant is a novel orally available highly selective metabotropic glutamate receptor subtype 5 negative allosteric modulator (mGlu5 NAM) which has completed Phase 1 and demonstrated efficacy in a Phase 2a proof of concept study for the treatment of levodopa-induced dyskinesia associated with Parkinson’s disease (PD-LID). This is a ...
Manufactured by:BioArctic AB based inStockholm, SWEDEN
BioArctic has developed a technology platform that has proven to be successful when the company’s first drug candidate was developed, the antibody BAN2401 for Alzheimer´s disease. Our mission is to improve quality of life for patients suffering from Central Nervous System (CNS) disorders. Patients with neurodegenerative disorders like Alzheimer’s ...
Manufactured by:Vala Sciences based inSan Diego, CALIFORNIA (USA)
By maintaining brain homeostasis, clearing cellular debris [3], pruning synapses [4], and eliminating protein aggregates [5], microglia play key roles in neurodevelopment [6], Alzheimer’s Disease [7], Parkinson’s Disease [8], ALS [9], traumatic brain injury [10], and many other central nervous system ...
Manufactured by:MedChemExpress LLC (MCE) based inMonmouth Junction, NEW JERSEY (USA)
P7C3 is an orally bioavailable and blood-brain barrier penetrant aminopropyl carbazole, with neuroprotective effects. P7C3 can be used for the research of neurodegenerative diseases, including Parkinson's ...